Yangjiang | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder	Active, not recruiting	Phase 4	2026-09-14		NCT04381143
Thrombus Aspiration in STEMI Patients With High Thrombus Burden	Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Recruiting	Not applicable	2026-09-09		NCT04212494
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers	Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder	Recruiting	Phase 4	2026-03-18		NCT05582174
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hypertensive disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 4	2025-02-26		NCT04974151
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hypertensive disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Recruiting	Phase 4	2025-02-26		NCT04974138